title: Restless legs syndrome.
abstract: Restless legs syndrome is a common neurologic movement disorder that affects approximately 10 percent of adults. Of those affected with this condition, approximately one third have symptoms severe enough to require medical therapy. Restless legs syndrome may be a primary condition, or it may be secondary to iron deficiency, renal failure, pregnancy, or the use of certain medications. The diagnosis is clinical, requiring an urge to move the legs usually accompanied by an uncomfortable sensation, occurrence at rest, improvement with activity, and worsening of symptoms in the evening or at night. Restless legs syndrome causes sleep disturbances, is associated with anxiety and depression, and has a negative effect on quality of life. Treatment of secondary causes of restless legs syndrome may result in improvement or resolution of symptoms. Currently, there is little information regarding the effects of lifestyle changes on the symptoms of restless legs syndrome. If medications are needed, dopamine agonists are the primary medications for moderate to severe restless legs syndrome. Other medications that may be effective include gabapentin, carbidopa/levodopa, opioids, and benzodiazepines.
authors.affiliation: Department of Family, East Tennessee State University, Quillen College of Medicine, Johnson City, Tennessee, USA. bayard@etsu.edu
authors.forename: Max
authors.initials: M
authors.lastname: Bayard
authors.forename: Thomas
authors.initials: T
authors.lastname: Avonda
authors.forename: James
authors.initials: J
authors.lastname: Wadzinski
mesh_terms: D002986:Clinical Trials as Topic; D018491:Dopamine Agonists / Q000627:therapeutic use*; D005081:Exercise Therapy; D006801:Humans; D012148:Restless Legs Syndrome / Q000175:diagnosis* / Q000188:drug therapy*
chemical_list: D018491:Dopamine Agonists